<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hip Knee Book &#187; Fda</title>
	<atom:link href="http://www.hipkneebook.com/tag/fda/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.hipkneebook.com</link>
	<description>Treating Arthritis of the Hip and Knee</description>
	<lastBuildDate>Thu, 29 Jul 2010 22:55:23 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Mylan gets FDA approval for generic arthritis drug</title>
		<link>http://www.hipkneebook.com/main-content/mylan-gets-fda-approval-for-generic-arthritis-drug/</link>
		<comments>http://www.hipkneebook.com/main-content/mylan-gets-fda-approval-for-generic-arthritis-drug/#comments</comments>
		<pubDate>Wed, 14 Jul 2010 20:26:41 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Drug]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fda Approval]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Generic Drug]]></category>
		<category><![CDATA[Generic Version]]></category>
		<category><![CDATA[Mylan]]></category>
		<category><![CDATA[Nabumetone]]></category>
		<category><![CDATA[Osteoarthritis]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>

		<guid isPermaLink="false">http://biz.yahoo.com/ap/100714/us_mylan_nabumetone.html?.v=1</guid>
		<description><![CDATA[Mylan Inc. said Wednesday the Food and Drug Administration approved its generic version of the osteoarthritis and rheumatoid arthritis drug Nabumetone.]]></description>
			<content:encoded><![CDATA[Mylan Inc. said Wednesday the Food and Drug Administration approved its generic version of the osteoarthritis and rheumatoid arthritis drug Nabumetone.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/mylan-gets-fda-approval-for-generic-arthritis-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Unsafe Rx: How long should the FDA wait?</title>
		<link>http://www.hipkneebook.com/main-content/unsafe-rx-how-long-should-the-fda-wait-2/</link>
		<comments>http://www.hipkneebook.com/main-content/unsafe-rx-how-long-should-the-fda-wait-2/#comments</comments>
		<pubDate>Mon, 05 Jul 2010 05:18:08 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Heart Risks]]></category>
		<category><![CDATA[Hormones]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Menopause]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Rx]]></category>
		<category><![CDATA[Vioxx]]></category>

		<guid isPermaLink="false">http://www.tdtnews.com/story/2010/7/5/67130</guid>
		<description><![CDATA[The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on.]]></description>
			<content:encoded><![CDATA[The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/unsafe-rx-how-long-should-the-fda-wait-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Unsafe Rx: How long should the FDA wait?</title>
		<link>http://www.hipkneebook.com/main-content/unsafe-rx-how-long-should-the-fda-wait/</link>
		<comments>http://www.hipkneebook.com/main-content/unsafe-rx-how-long-should-the-fda-wait/#comments</comments>
		<pubDate>Sun, 04 Jul 2010 05:16:49 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Heart Risks]]></category>
		<category><![CDATA[Hormones]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Menopause]]></category>
		<category><![CDATA[Multiple Sclerosis]]></category>
		<category><![CDATA[Rx]]></category>
		<category><![CDATA[Vioxx]]></category>

		<guid isPermaLink="false">http://www.tdtnews.com/story/2010/7/4/67130</guid>
		<description><![CDATA[The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on.]]></description>
			<content:encoded><![CDATA[The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/unsafe-rx-how-long-should-the-fda-wait/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NicOx fails to get US FDA panel support for naproxcinod MAA</title>
		<link>http://www.hipkneebook.com/main-content/nicox-fails-to-get-us-fda-panel-support-for-naproxcinod-maa/</link>
		<comments>http://www.hipkneebook.com/main-content/nicox-fails-to-get-us-fda-panel-support-for-naproxcinod-maa/#comments</comments>
		<pubDate>Sat, 15 May 2010 03:50:13 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Abstention]]></category>
		<category><![CDATA[Advisory Committees]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Drugs]]></category>
		<category><![CDATA[Drug Safety]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fda Panel]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Food And Drug Administration Fda]]></category>
		<category><![CDATA[Maa]]></category>
		<category><![CDATA[Management Advisory Committee]]></category>
		<category><![CDATA[Nicox]]></category>
		<category><![CDATA[Risk Management]]></category>
		<category><![CDATA[Signs And Symptoms]]></category>
		<category><![CDATA[Us Food And Drug Administration]]></category>

		<guid isPermaLink="false">http://www.pharmabiz.com/article/detnews.asp?articleid=55473</guid>
		<description><![CDATA[NicOx SA announced that the Joint Advisory Committees of the US Food and Drug Administration (FDA), including the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, voted by 16 to one with one abstention that they did not have sufficient evidence at this time to support the approval of naproxcinod for the relief of the signs and symptoms of ...]]></description>
			<content:encoded><![CDATA[NicOx SA announced that the Joint Advisory Committees of the US Food and Drug Administration (FDA), including the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, voted by 16 to one with one abstention that they did not have sufficient evidence at this time to support the approval of naproxcinod for the relief of the signs and symptoms of ...]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/nicox-fails-to-get-us-fda-panel-support-for-naproxcinod-maa/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NicOx Shares Tumble On FDA View On Arthritis Drug</title>
		<link>http://www.hipkneebook.com/main-content/nicox-shares-tumble-on-fda-view-on-arthritis-drug/</link>
		<comments>http://www.hipkneebook.com/main-content/nicox-shares-tumble-on-fda-view-on-arthritis-drug/#comments</comments>
		<pubDate>Tue, 11 May 2010 08:01:05 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Drug]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Shares]]></category>

		<guid isPermaLink="false">http://feeds.foxbusiness.com/~r/foxbusiness/latest/~3/R5aqe6PZzb0/</guid>
		<description><![CDATA[NicOx Shares Tumble On FDA View On Arthritis Drug]]></description>
			<content:encoded><![CDATA[NicOx Shares Tumble On FDA View On Arthritis Drug]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/nicox-shares-tumble-on-fda-view-on-arthritis-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA approves AstraZeneca-POZEN arthritis drug</title>
		<link>http://www.hipkneebook.com/main-content/fda-approves-astrazeneca-pozen-arthritis-drug-5/</link>
		<comments>http://www.hipkneebook.com/main-content/fda-approves-astrazeneca-pozen-arthritis-drug-5/#comments</comments>
		<pubDate>Fri, 07 May 2010 12:17:27 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Drug]]></category>
		<category><![CDATA[Arthritis Medicines]]></category>
		<category><![CDATA[Arthritis Pain Relief]]></category>
		<category><![CDATA[Arthritis Relief]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fda Approved]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Food And Drug Administration Fda]]></category>
		<category><![CDATA[Gastric Ulcers]]></category>
		<category><![CDATA[Pain Medicines]]></category>
		<category><![CDATA[Pozen Inc]]></category>
		<category><![CDATA[Release Tablets]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[Types Of Arthritis]]></category>

		<guid isPermaLink="false">http://www.ledgerdelaware.com/articles/2010/05/07/news/doc4bdee8cd0afff118028014.txt</guid>
		<description><![CDATA[AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.]]></description>
			<content:encoded><![CDATA[AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/fda-approves-astrazeneca-pozen-arthritis-drug-5/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA approves AstraZeneca-POZEN arthritis drug</title>
		<link>http://www.hipkneebook.com/main-content/fda-approves-astrazeneca-pozen-arthritis-drug-4/</link>
		<comments>http://www.hipkneebook.com/main-content/fda-approves-astrazeneca-pozen-arthritis-drug-4/#comments</comments>
		<pubDate>Thu, 06 May 2010 13:46:36 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Drug]]></category>
		<category><![CDATA[Arthritis Medicines]]></category>
		<category><![CDATA[Arthritis Pain Relief]]></category>
		<category><![CDATA[Arthritis Relief]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fda Approved]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Food And Drug Administration Fda]]></category>
		<category><![CDATA[Gastric Ulcers]]></category>
		<category><![CDATA[Pain Medicines]]></category>
		<category><![CDATA[Pozen Inc]]></category>
		<category><![CDATA[Release Tablets]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[Types Of Arthritis]]></category>

		<guid isPermaLink="false">http://www.ledgerdelaware.com/articles/2010/05/06/news/doc4bdee8cd0afff118028014.txt</guid>
		<description><![CDATA[AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.]]></description>
			<content:encoded><![CDATA[AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/fda-approves-astrazeneca-pozen-arthritis-drug-4/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA approves AstraZeneca-POZEN arthritis drug</title>
		<link>http://www.hipkneebook.com/main-content/fda-approves-astrazeneca-pozen-arthritis-drug-3/</link>
		<comments>http://www.hipkneebook.com/main-content/fda-approves-astrazeneca-pozen-arthritis-drug-3/#comments</comments>
		<pubDate>Wed, 05 May 2010 10:44:36 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Drug]]></category>
		<category><![CDATA[Arthritis Medicines]]></category>
		<category><![CDATA[Arthritis Pain Relief]]></category>
		<category><![CDATA[Arthritis Relief]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fda Approved]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Food And Drug Administration Fda]]></category>
		<category><![CDATA[Gastric Ulcers]]></category>
		<category><![CDATA[Pain Medicines]]></category>
		<category><![CDATA[Pozen Inc]]></category>
		<category><![CDATA[Release Tablets]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[Types Of Arthritis]]></category>

		<guid isPermaLink="false">http://www.ledgerdelaware.com/articles/2010/05/05/news/doc4bdee8cd0afff118028014.txt</guid>
		<description><![CDATA[AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.]]></description>
			<content:encoded><![CDATA[AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/fda-approves-astrazeneca-pozen-arthritis-drug-3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA approves AstraZeneca-POZEN arthritis drug</title>
		<link>http://www.hipkneebook.com/main-content/fda-approves-astrazeneca-pozen-arthritis-drug-2/</link>
		<comments>http://www.hipkneebook.com/main-content/fda-approves-astrazeneca-pozen-arthritis-drug-2/#comments</comments>
		<pubDate>Tue, 04 May 2010 11:58:56 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Drug]]></category>
		<category><![CDATA[Arthritis Medicines]]></category>
		<category><![CDATA[Arthritis Pain Relief]]></category>
		<category><![CDATA[Arthritis Relief]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fda Approved]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Food And Drug Administration Fda]]></category>
		<category><![CDATA[Gastric Ulcers]]></category>
		<category><![CDATA[Pain Medicines]]></category>
		<category><![CDATA[Pozen Inc]]></category>
		<category><![CDATA[Release Tablets]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[Types Of Arthritis]]></category>

		<guid isPermaLink="false">http://www.ledgerdelaware.com/articles/2010/05/04/news/doc4bdee8cd0afff118028014.txt</guid>
		<description><![CDATA[AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.]]></description>
			<content:encoded><![CDATA[AstraZeneca and POZEN Inc. announced the U.S. Food and Drug Administration (FDA) approved VIMOVO delayed-release tablets for the relief of arthritis. The drug reduces the risk of getting gastric ulcers associated with taking some types of arthritis pain relief medicines.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/fda-approves-astrazeneca-pozen-arthritis-drug-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA green lights Astra&#8217;s arthritis pill</title>
		<link>http://www.hipkneebook.com/main-content/fda-green-lights-astras-arthritis-pill/</link>
		<comments>http://www.hipkneebook.com/main-content/fda-green-lights-astras-arthritis-pill/#comments</comments>
		<pubDate>Tue, 04 May 2010 07:14:07 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Anglo]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Sufferers]]></category>
		<category><![CDATA[Astra]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[Drugs]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fda Approved]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Food And Drug Administration Fda]]></category>
		<category><![CDATA[Giant]]></category>
		<category><![CDATA[London]]></category>
		<category><![CDATA[Pain Relief]]></category>
		<category><![CDATA[Sharecast]]></category>
		<category><![CDATA[Us Food And Drug Administration]]></category>

		<guid isPermaLink="false">http://www.sharecast.com/cgi-bin/sharecast/story.cgi?story_id=3433685</guid>
		<description><![CDATA[LONDON (SHARECAST) - Anglo-Swedish drugs giant AstraZeneca said the US Food and Drug Administration (FDA) has approved VIMOVO, the pain relief pill for arthritis sufferers.]]></description>
			<content:encoded><![CDATA[LONDON (SHARECAST) - Anglo-Swedish drugs giant AstraZeneca said the US Food and Drug Administration (FDA) has approved VIMOVO, the pain relief pill for arthritis sufferers.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/fda-green-lights-astras-arthritis-pill/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
